[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Technology](https://github.com/mm80843/T3.5/tree/main/docs/Technology/index.md) >> Individual ID:PBN__Technology_3920 

# __protease inhibitors__

## Category to which it belongs

* [Advancements in biotechnology, clinical research, and innovative therapies contribute to the development of medical solutions.](https://github.com/mm80843/T3.5/blob/main/docs/PBNCategory/PBN__PBNCategory_204.md)

## Closest similar item

* [identification of potential therapeutic targets](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_1956.md)
* [antiviral](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3919.md)
* [antiviral drugs](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_236.md)
* [antivirals](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_829.md)
* [medications](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3886.md)
* [anti-malaria drugs](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_237.md)
* [anti-inflammatory drugs](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_238.md)
* [antimalarial](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3918.md)
* [anti-bacterial](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3917.md)
* [clinical trials](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_1961.md)

## This Technology enables the following mitigations

* [Use of specific medicines](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_1555.md)

